These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4032797)

  • 1. [Pharmacology of calcium channel blockers].
    Kuwahara T; Kawai C; Matsunaga M
    Nihon Rinsho; 1985 May; 43(5):978-82. PubMed ID: 4032797
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic and regional haemodynamic effects of vasodilators in hypertension.
    Struyker-Boudier HA; Smits JF
    Neth J Med; 1984; 27(4):146-52. PubMed ID: 6330588
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
    Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
    Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists in the treatment of hypertension: a critical overview.
    Weidmann P; Gerber A; Laederach K
    Adv Nephrol Necker Hosp; 1985; 14():197-232. PubMed ID: 3919532
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of a new calcium antagonist on hemodynamics at rest and exercise loading in patients with essential hypertension.
    Suzuki S; Hashimoto T; Kusano S; Kapuku K; Utsunomiya T; Yano K
    Arzneimittelforschung; 1993 Nov; 43(11):1152-6. PubMed ID: 8292057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasodilators in the treatment of hypertension].
    Huysmans FT; Thien TA
    Ned Tijdschr Geneeskd; 1989 Mar; 133(12):595-9. PubMed ID: 2716872
    [No Abstract]   [Full Text] [Related]  

  • 7. [What is safe in the therapy of hypertensive heart disease?].
    Motz W; Strauer BE
    Internist (Berl); 1985 Dec; 26(12):750-64. PubMed ID: 2867983
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension update for the 1980s.
    Lowenthal DT; Swartz CD
    Prim Care; 1985 Mar; 12(1):101-15. PubMed ID: 2859624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current problems in hypotensive treatment].
    Sznajderman M
    Wiad Lek; 1983 Mar; 36(5):413-24. PubMed ID: 6135281
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of calcium channel blockers on cardiovascular responses to smoking in normotensive and hypertensive smokers.
    Fogari R; Zoppi A; Malamani GD; Corradi L
    Int J Clin Pharmacol Res; 1992; 12(2):81-8. PubMed ID: 1428302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium channel blockers and tissue remodeling in hypertension].
    Godfraind T
    Bull Mem Acad R Med Belg; 2001; 156(3-4):165-73; discussion 173-4. PubMed ID: 11789397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension medications and dental considerations.
    Wynn RL
    Gen Dent; 2000; 48(2):126-31. PubMed ID: 11199569
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
    Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
    G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
    Basile J
    J Clin Hypertens (Greenwich); 2002; 4(6):434-5. PubMed ID: 12461310
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of calcium-channel blockers and beta-blockers in essential hypertension: clinical implications.
    Massie BM; Tubau JF; Szlachcic J
    Circulation; 1987 Jun; 75(6 Pt 2):V163-9. PubMed ID: 2882873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium channel blockers with delayed effect in the treatment of arterial hypertension. A short-term study].
    Bardan V; Pop G; Leniş M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(6):541-50. PubMed ID: 2908157
    [No Abstract]   [Full Text] [Related]  

  • 18. [Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation].
    Pimenov LT; Ezhov AV; Churshin AD
    Klin Med (Mosk); 1995; 73(5):69-71. PubMed ID: 8815289
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium-channel blockers and systemic hypertension.
    Frishman WH; Charlap S; Ocken S; Spivack C
    J Clin Hypertens; 1985 Jun; 1(2):107-22. PubMed ID: 3915318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
    Engberding R; Bender F; Gülker H; Specker E; Molinski M
    Z Kardiol; 1984 Aug; 73(8):498-503. PubMed ID: 6495809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.